These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience. Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875 [TBL] [Abstract][Full Text] [Related]
8. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100 [TBL] [Abstract][Full Text] [Related]
9. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253 [TBL] [Abstract][Full Text] [Related]
10. Pituitary function after selective adenomectomy for Cushing's disease. Post FA; Soule SG; De Villiers JC; Levitt NS Br J Neurosurg; 1995; 9(1):41-6. PubMed ID: 7786425 [TBL] [Abstract][Full Text] [Related]
11. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. Sanno N; Teramoto A; Osamura RY J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003 [TBL] [Abstract][Full Text] [Related]
17. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence. Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640 [TBL] [Abstract][Full Text] [Related]